Stocks Overview

LAST PRICE
33.3400
TODAY'S CHANGE (%)
Trending Up0.9900 (3.0603%)

Bid / Lots
32.8100/ 30
Ask / Lots
34.2000/ 3
Open / Previous Close
32.9300 / 32.3500
Day Range
Low 32.5600
High 33.6850
52 Week Range
Low 20.8400
High 35.2200
Volume
941,859
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Monday's close: 32.35
Time	Volume	CORT
09:32 ET	7749	32.92
09:34 ET	700	32.775
09:36 ET	2274	33.05
09:38 ET	1000	33.015
09:39 ET	15655	33.34
09:41 ET	4700	33.4
09:43 ET	2800	33.48
09:45 ET	4107	33.46
09:48 ET	6125	33.48
09:50 ET	13729	33.455
09:52 ET	2400	33.49
09:54 ET	6446	33.58
09:56 ET	2154	33.53
09:57 ET	10744	33.605
09:59 ET	1500	33.64
10:01 ET	3544	33.46
10:03 ET	1200	33.4
10:06 ET	600	33.38
10:08 ET	600	33.38
10:10 ET	900	33.375
10:12 ET	1800	33.35
10:14 ET	6843	33.42
10:15 ET	21143	33.54
10:17 ET	1500	33.395
10:19 ET	1809	33.44
10:21 ET	2746	33.5
10:24 ET	2186	33.52
10:26 ET	600	33.53
10:28 ET	2000	33.5
10:30 ET	1167	33.465
10:32 ET	3052	33.365
10:33 ET	1620	33.3
10:35 ET	3585	33.25
10:37 ET	5752	33.23
10:39 ET	10341	33.24
10:42 ET	6757	33.14
10:44 ET	14152	32.9476
10:46 ET	2433	32.78
10:48 ET	6953	32.995
10:50 ET	1900	33.025
10:51 ET	5645	32.93
10:53 ET	3200	32.64
10:55 ET	2773	32.67
10:57 ET	3001	32.65
11:00 ET	2937	32.57
11:02 ET	7130	32.62
11:04 ET	3726	32.76
11:06 ET	3000	32.65
11:08 ET	4149	32.62
11:09 ET	4104	32.8
11:11 ET	3852	32.95
11:13 ET	2513	33.1
11:15 ET	5209	33.125
11:18 ET	688	33.14
11:20 ET	2100	33.04
11:22 ET	1600	33.11
11:24 ET	2233	33.1
11:26 ET	1900	33.155
11:27 ET	200	33.17
11:29 ET	1094	33.185
11:31 ET	1400	33.2
11:33 ET	1815	33.175
11:36 ET	596	33.18
11:38 ET	2663	33.14
11:40 ET	842	33.23
11:42 ET	617	33.17
11:44 ET	400	33.13
11:45 ET	4037	33.155
11:47 ET	914	33.12
11:49 ET	4489	33.0225
11:51 ET	715	33.02
11:54 ET	200	33.02
11:56 ET	2490	33.09
11:58 ET	1864	33.06
12:00 ET	448	33.075
12:02 ET	400	33.09
12:03 ET	1000	33.11
12:05 ET	1033	33.14
12:07 ET	1375	33.1
12:09 ET	133	33.1
12:12 ET	2100	33.15
12:14 ET	2601	33.12
12:16 ET	974	33.11
12:18 ET	300	33.01
12:20 ET	455	33.04
12:21 ET	1200	33.1
12:23 ET	115	33.1
12:25 ET	227	33.1
12:27 ET	3785	33.11
12:30 ET	550	33.13
12:32 ET	700	33.15
12:34 ET	300	33.1125
12:36 ET	425	33.115
12:38 ET	1498	33.135
12:39 ET	610	33.16
12:41 ET	100	33.135
12:43 ET	900	33.125
12:45 ET	868	33.02
12:48 ET	1492	33.05
12:50 ET	1252	33.11
12:52 ET	300	33.085
12:54 ET	1100	33.14
12:56 ET	1055	33.155
12:57 ET	100	33.12
12:59 ET	1677	33.15
01:01 ET	200	33.1
01:06 ET	210	33.1112
01:08 ET	543	33.1236
01:10 ET	1107	33.195
01:12 ET	100	33.18
01:14 ET	762	33.18
01:15 ET	300	33.21
01:17 ET	491	33.1819
01:19 ET	128	33.21
01:21 ET	4566	33.271
01:24 ET	2702	33.35
01:26 ET	1300	33.31
01:28 ET	368	33.325
01:30 ET	179	33.325
01:32 ET	1545	33.35
01:33 ET	1000	33.26
01:35 ET	1409	33.3
01:37 ET	700	33.3
01:39 ET	3091	33.31
01:42 ET	850	33.31
01:44 ET	1400	33.35
01:46 ET	3118	33.4576
01:48 ET	1973	33.43
01:50 ET	1133	33.45
01:51 ET	1535	33.35
01:53 ET	200	33.35
01:55 ET	2243	33.415
01:57 ET	700	33.335
02:00 ET	5966	33.385
02:02 ET	586	33.38
02:04 ET	2190	33.38
02:06 ET	668	33.3775
02:08 ET	944	33.35
02:09 ET	2366	33.36
02:11 ET	654	33.37
02:13 ET	1400	33.35
02:15 ET	666	33.34
02:18 ET	1664	33.32
02:20 ET	2046	33.28
02:22 ET	1874	33.305
02:24 ET	300	33.29
02:26 ET	166	33.305
02:27 ET	1131	33.34
02:29 ET	2403	33.34
02:31 ET	1200	33.38
02:33 ET	1900	33.36
02:36 ET	500	33.33
02:38 ET	3820	33.31
02:40 ET	273	33.295
02:42 ET	500	33.34
02:44 ET	365	33.37
02:45 ET	1350	33.36
02:47 ET	1831	33.385
02:49 ET	3938	33.46
02:51 ET	2588	33.4106
02:54 ET	1742	33.41
02:56 ET	750	33.45
02:58 ET	739	33.465
03:00 ET	2379	33.49
03:02 ET	596	33.5125
03:03 ET	5908	33.5
03:05 ET	2315	33.575
03:07 ET	3300	33.59
03:09 ET	2595	33.6
03:12 ET	3900	33.57
03:14 ET	2331	33.62
03:16 ET	8006	33.53
03:18 ET	1867	33.56
03:20 ET	1376	33.57
03:21 ET	2152	33.435
03:23 ET	1700	33.5
03:25 ET	2437	33.52
03:27 ET	403	33.54
03:30 ET	1516	33.53
03:32 ET	5100	33.55
03:34 ET	1983	33.56
03:36 ET	801	33.51
03:38 ET	1114	33.48
03:39 ET	2153	33.465
03:41 ET	1365	33.42
03:43 ET	2929	33.45
03:45 ET	2779	33.37
03:48 ET	1272	33.41
03:50 ET	1800	33.36
03:52 ET	7042	33.41
03:54 ET	7834	33.44
03:56 ET	16669	33.51
03:57 ET	21925	33.34
03:59 ET	24578	33.34

Data delayed at least 15 minutes.

Jul 1, 2024
- DJ Corcept Therapeutics Price Target Maintained With a $35.00/Share by Piper Sandler, from 9:54AM ET on Monday Jul 01, 2024 by Dow Jones
  9:54AM ET on Monday Jul 01, 2024 by Dow Jones
Jun 24, 2024
- Corcept Announces Presentation of Results From Prevalence Phase of CATALYST Clinical Trial at American Diabetes Association's Scientific Sessions, from 4:15PM ET on Monday Jun 24, 2024 by Dow Jones
  4:15PM ET on Monday Jun 24, 2024 by Dow Jones
Jun 17, 2024
- DJ Corcept Therapeutics Is Maintained at Buy by Truist Securities, from 11:37AM ET on Monday Jun 17, 2024 by Dow Jones
  11:37AM ET on Monday Jun 17, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesCORT Corcept Therapeutics Inc	3.4B	31.2x	+9.80%
United StatesHRMY Harmony Biosciences Holdings Inc	1.9B	15.0x	---
United StatesANIP ANI Pharmaceuticals Inc	1.3B	40.3x	-8.16%
United StatesHCM HUTCHMED (China) Ltd	3.3B	32.5x	---
United StatesAMPH Amphastar Pharmaceuticals Inc	1.9B	13.7x	---
United StatesTLRY Tilray Brands Inc	1.6B	-3.9x	---
As of 2024-07-16

Corcept Therapeutics Incorporated is a commercial-stage company, which is engaged in the discovery and development of medications to treat severe endocrine, oncologic, metabolic and neurological disorders by modulating the effects of the hormone cortisol. The Company operates through the discovery, development and commercialization of the pharmaceutical products segment. The Company has marketed Korlym (mifepristone) in the United States for the treatment of patients suffering from Cushings syndrome. The Company’s portfolio of selective cortisol modulators consists of four series totaling approximately 1,000 compounds. Its portfolio of selective cortisol modulators consists of relacorilant, exicorilant, dazucorilant and miricorilant. Korlyms active ingredient, mifepristone, reduces the binding of excess cortisol to the GR, it can modulate the effects of abnormal levels and release patterns of cortisol without compromising cortisols healthy functions and rhythms.

Contact Information

Headquarters: 149 Commonwealth DrMENLO PARK, CA, United States 94025
Phone: 650-688-8803
Fax: 650-327-3218

Executives

Independent Chairman of the Board: James Wilson
President, Chief Executive Officer, Co-Founder, Director: Joseph Belanoff
Chief Financial Officer, Treasurer: Atabak Mokari
President - Corcept Endocrinology: Sean Maduck
President - Oncology: Roberto Vieira

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$3.4B
Revenue (TTM)	$523.5M
Shares Outstanding	104.1M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	0.43
EPS	$1.07
Book Value	$4.90
P/E Ratio	31.2x
Price/Sales (TTM)	6.4
Price/Cash Flow (TTM)	28.3x
Operating Margin	23.29%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Corcept Therapeutics Inc
NASDAQ:CORTUnited States

Search Criteria

Charts

Recent News

Jul 1, 2024

DJ Corcept Therapeutics Price Target Maintained With a $35.00/Share by Piper Sandler, from 9:54AM ET on Monday Jul 01, 2024 by Dow Jones

Jun 24, 2024

Corcept Announces Presentation of Results From Prevalence Phase of CATALYST Clinical Trial at American Diabetes Association's Scientific Sessions, from 4:15PM ET on Monday Jun 24, 2024 by Dow Jones

Jun 17, 2024

DJ Corcept Therapeutics Is Maintained at Buy by Truist Securities, from 11:37AM ET on Monday Jun 17, 2024 by Dow Jones

Pharmaceuticals - Diversified Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar